Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NBIX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Neurocrine Biosciences Inc (NBIX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Neurocrine Biosciences (NBIX) trades at $138.12, down 0.59% on the day, with technical indicators showing bearish momentum despite oversold RSI readings. The company demonstrates strong fundamentals with 2025 revenue of $2.86 billion and net income of $478.6 million, achieving a 20.91% net margin. Recent earnings show mixed results with Q2 2026 missing expectations, while analyst sentiment remains overwhelmingly positive with 86% buy ratings and a $203.82 consensus price target representing 48% upside potential.
NBIX presents a compelling growth story with robust profitability and strong institutional support, though near-term technical weakness and execution risks around pipeline development warrant caution. The stock's current valuation at 20.23x P/E appears reasonable given the company's earnings growth trajectory and expanding rare-disease portfolio, making it attractive for long-term investors despite recent price pressure.
Read full analysis

Key Stats

  • Market Cap
    $14.07B
  • Volume
    1,145,466
  • Sector
    Health
  • 52W High
    $185.50
  • 52W Low
    $123.10
  • Typical Hold Time
    21 Days
  • Enterprise Value
    $14.08B
  • Div Yield
    -
  • Trading Activity
    -
$138.12
52W Low: $123.1
12 Feb 2026
52W High: $185.5
30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Most Recent News

Content is generated by Aura AI

China's industrial profits rise 4.2% in August despite weak demand and rising energy costs

China's industrial profits increased by 4.2% in August compared to the previous year, driven by growth in sectors like artificial intelligence and computing equipment. However, this growth is slowing, with profits rising 15.7% in the first eight mont...

Market News
4 hours ago
CNBC
Neutral
China's industrial profits rise 4.2% in August despite weak demand and rising energy costs

Northern Star shares jump 11% after rejecting Gold Fields' undervalued takeover bid.

Northern Star Resources shares surged nearly 11% after rejecting a takeover proposal from Gold Fields, which the board called "highly opportunistic" and undervalued the company. The offer included a mix of Gold Fields shares and cash but was criticiz...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Northern Star shares jump 11% after rejecting Gold Fields' undervalued takeover bid.

Northern Star rejects $27B takeover bid from Gold Fields, shares jump 9%.

Northern Star Resources rejected a $27 billion takeover offer from South Africa's Gold Fields, stating the bid undervalued the company and was opportunistic. The proposal included a mix of shares and cash but was seen as falling short of Northern Sta...

Market News
4 hours ago
CNBC
Bullish
news icon
Northern Star rejects $27B takeover bid from Gold Fields, shares jump 9%.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $14.07B
  • Volume
    1,145,466
  • Sector
    Health
  • 52W High
    $185.50
  • 52W Low
    $123.10
  • Typical Hold Time
    21 Days
  • Enterprise Value
    $14.08B
  • Div Yield
    -
  • Trading Activity
    -
$138.12
52W Low: $123.1
12 Feb 2026
52W High: $185.5
30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!